local_hospital

Klinik für Kinder- und Jugendmedizin der Ruhr-Universität Bochum im St. Josef-Hospital

Address
Alexandrinenstraße 5, Nordrhein-Westfalen, 44791 Bochum, Germany

Klinik für Kinder- und Jugendmedizin der Ruhr-Universität Bochum im St. Josef-Hospital

The Department of Pediatrics and Adolescent Medicine at Ruhr University Bochum, located at St. Josef Hospital, is a leading clinical research center dedicated to improving health outcomes for children and adolescents. The center specializes in investigating both acute and chronic conditions affecting pediatric populations, with particular emphasis on neurological disorders and dermatological conditions in young patients.

  • Pediatric migraine treatment and innovative therapeutic interventions for children aged 6 to 17
  • Prevention of atopic dermatitis in high-risk infants through early intervention strategies
  • Long-term pediatric disease prevention and management studies

The clinic conducts comprehensive clinical trials evaluating both pharmacological treatments and preventive care approaches. Their research portfolio includes studies on novel migraine medications such as lasmiditan for pediatric patients, as well as preventive dermatology trials examining the efficacy of topical treatments in reducing the incidence of atopic dermatitis in at-risk infants. The center's commitment to pediatric research extends across multiple age groups, from infancy through adolescence, ensuring age-appropriate and evidence-based care for young patients.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
2
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
2
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 2 161 other sites in Germany

description
Trial volume
2
Outperforms 47% of sites
public
Therapeutic diversity
2areas
Outperforms 62% of sites
groups
Sponsor diversity
2sponsors
Outperforms 51% of sites

Therapeutic Area Benchmark — Germany

Select a therapeutic area to compare against other sites in Germany.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Germany

Market Share

Country: Germany

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Klinik für Kinder- und Jugendmedizin der Ruhr-Universität Bochum im St. Josef-Hospital

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Paraffin White Soft Cream for Prophylaxis of Atopic Dermatitis in High-Risk Pediatric Populations: A Randomized, Investigator-Blinded StudyINFECTOPHARM Arzneimittel und Consilium GmbHPhase IIINot RecruitingJan 2020

IMP list

lock Showing 1 of 2 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Lasmiditan1Unknown2020-11-092020-11-09

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.